Literature DB >> 16887976

Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation.

Fabienne Billiard1, Elena Litvinova, David Saadoun, Fathia Djelti, David Klatzmann, José L Cohen, Gilles Marodon, Benoît L Salomon.   

Abstract

Little is known about the in vivo conditions in which CD4+CD25+ regulatory T cells (T(reg)) exert their suppressive effect in nonlymphopenic mice. To this end, we analyzed T(reg)-mediated suppression of expansion and cytokine production at different levels of Ag-specific CD4+CD25- T cell activation. Using Ab-mediated depletion of endogenous T(reg), we show that basal immunosuppression is dependent on effector T cell activation. These polyclonal T(reg), which were poorly activated in our immunization conditions, were effective in weak but not high T cell activation context. In contrast, the same immunization conditions led to proliferation of cotransferred Ag-specific T(reg). Those efficiently inhibited T cell proliferation and cytokine production even in strong T cell activation context. Interestingly, T(reg) selectively suppressed expansion or cytokine production depending on the experimental approach. The importance of the immune context for efficient suppression is further supported by the observation that T(reg) depletion exacerbated diabetes of NOD mice only at the early stage of the disease. Overall, our study suggests that T(reg)-mediated suppression depends on the relative activation of T(reg) and effector T cells in vivo. This balance may be a critical factor in the regulation of immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887976     DOI: 10.4049/jimmunol.177.4.2167

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  A role for anti-CD45RB monoclonal antibody treatment upon dendritic cells.

Authors:  Hui Qi; Jin-Peng Liu; Chun-Yan Deng; Han-Xin Zhou; Shao-Ping Deng; Fu-Rong Li
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants.

Authors:  Wilfred Ndifon
Journal:  J R Soc Interface       Date:  2015-11-06       Impact factor: 4.118

3.  Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.

Authors:  Yenkel Grinberg-Bleyer; David Saadoun; Audrey Baeyens; Fabienne Billiard; Jérémie D Goldstein; Sylvie Grégoire; Gaëlle H Martin; Rima Elhage; Nicolas Derian; Wassila Carpentier; Gilles Marodon; David Klatzmann; Eliane Piaggio; Benoît L Salomon
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

4.  Allograft rejection mediated by memory T cells is resistant to regulation.

Authors:  Jaeseok Yang; Matthew O Brook; Manuela Carvalho-Gaspar; Jidong Zhang; Hilda E Ramon; Mohamed H Sayegh; Kathryn J Wood; Laurence A Turka; Nick D Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

Review 5.  The development and function of regulatory T cells.

Authors:  Creg J Workman; Andrea L Szymczak-Workman; Lauren W Collison; Meenu R Pillai; Dario A A Vignali
Journal:  Cell Mol Life Sci       Date:  2009-04-24       Impact factor: 9.261

6.  Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice.

Authors:  Ł Krych; D S Nielsen; A K Hansen; C H F Hansen
Journal:  Gut Microbes       Date:  2015-02-03

7.  TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies.

Authors:  Tristan Courau; Djamel Nehar-Belaid; Laura Florez; Béatrice Levacher; Thomas Vazquez; Faustine Brimaud; Bertrand Bellier; David Klatzmann
Journal:  JCI Insight       Date:  2016-06-16

8.  An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes.

Authors:  D Ly; R Tohn; B Rubin; H Blumenfeld; G S Besra; N Veerapen; S A Porcelli; T L Delovitch
Journal:  Clin Exp Immunol       Date:  2009-12-15       Impact factor: 4.330

9.  FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions.

Authors:  Cécile Taflin; Makoto Miyara; Dominique Nochy; Dominique Valeyre; Jean-Marc Naccache; Frédéric Altare; Pascale Salek-Peyron; Cécile Badoual; Patrick Bruneval; Julien Haroche; Alexis Mathian; Zahir Amoura; Gary Hill; Guy Gorochov
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

10.  Antigen quality determines the efficiency of antitumor immune responses generated in the absence of regulatory T cells.

Authors:  A-S Bergot; A Durgeau; B Levacher; B M Colombo; J L Cohen; D Klatzmann
Journal:  Cancer Gene Ther       Date:  2010-05-14       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.